Aldeyra Therapeutics, Inc. (ALDX)
NASDAQ: ALDX · Real-Time Price · USD
6.91
+0.10 (1.47%)
Mar 14, 2025, 4:00 PM EDT - Market closed
Aldeyra Therapeutics Employees
Aldeyra Therapeutics had 9 employees as of December 31, 2024. The number of employees decreased by 1 or -10.00% compared to the previous year.
Employees
9
Change (1Y)
-1
Growth (1Y)
-10.00%
Revenue / Employee
n/a
Profits / Employee
-$6,205,716
Market Cap
412.59M
Employees Chart
ALDX News
- 5 days ago - Aldeyra Therapeutics to Participate in the 2025 Leerink Partners Global Healthcare Conference - Business Wire
- 9 days ago - Aldeyra Therapeutics Is Severely Undervalued Before PDUFA - Seeking Alpha
- 5 weeks ago - Aldeyra Therapeutics to Participate in Oppenheimer's 35th Annual Healthcare Life Sciences Conference - Business Wire
- 2 months ago - Aldeyra Therapeutics: Key Inflection Point Ahead - Seeking Alpha
- 3 months ago - Aldeyra Therapeutics to Participate in the Citi 2024 Global Healthcare Conference - Business Wire
- 4 months ago - Aldeyra Therapeutics Announces FDA Acceptance for Review of Reproxalap New Drug Application for the Treatment of Dry Eye Disease, Expands AbbVie Option Agreement - Business Wire
- 4 months ago - Aldeyra Therapeutics to Participate in the Jefferies London Healthcare Conference - Business Wire
- 4 months ago - Aldeyra's FDA Resubmission And AbbVie Option Revitalize Reproxalap's Prospects - Seeking Alpha